Liquidia Announces the Publication of Long-Term Clinical Data from Completed INSPIRE Study in the Journal Pulmonary Circulation
01 août 2022 07h46 HE
|
Liquidia Corporation
Evaluated doses of YUTREPIA™ (treprostinil) inhalation powder from 26.5 mcg to 212 mcg which are comparable to 3 to 24 breaths of nebulized Tyvaso® per sessionAchieved therapeutic levels by Month 2...
Liquidia to Participate in Upcoming Investor Conferences
01 août 2022 06h24 HE
|
Liquidia Corporation
MORRISVILLE, N.C., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will be participating at the following investor conferences next week: BTIG...
Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
25 juil. 2022 08h51 HE
|
Liquidia Corporation
MORRISVILLE, N.C., July 25, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of an inducement stock option exercisable for 2,000 shares of Liquidia’s common...
Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
21 juil. 2022 16h30 HE
|
Liquidia Corporation
MORRISVILLE, N.C., July 21, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that, in connection with the previously announced appointment of Rajeev Saggar, M.D.,...
Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent
19 juil. 2022 16h30 HE
|
Liquidia Corporation
MORRISVILLE, N.C., July 19, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (PTAB) ruled in its favor in the Inter Partes...
Liquidia Corporation Added to Russell 2000® and 3000® Indexes
27 juin 2022 06h26 HE
|
Liquidia Corporation
MORRISVILLE, N.C., June 27, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the company was added as a member of the US small-cap Russell 2000® Index, effective...
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
24 juin 2022 16h15 HE
|
Liquidia Corporation
MORRISVILLE, N.C., June 24, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of inducement stock options exercisable for an aggregate of 24,800 shares of...
Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
24 juin 2022 09h35 HE
|
Liquidia Corporation
MORRISVILLE, N.C., June 24, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of an inducement stock option exercisable for 2,000 shares of Liquidia’s common...
Liquidia Appoints Rajeev Saggar, M.D., as Chief Medical Officer
20 juin 2022 07h00 HE
|
Liquidia Corporation
MORRISVILLE, N.C., June 20, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced the appointment of Rajeev Saggar, M.D., to the position of...
Liquidia Announces Presentation at the 2022 Pulmonary Hypertension Association (PHA) International Conference
09 juin 2022 16h30 HE
|
Liquidia Corporation
MORRISVILLE, N.C., June 09, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced the presentation of data related to the investigational use of...